These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 3115933

  • 41. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF, Huang P, Plunkett W, Gandhi V.
    Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
    [Abstract] [Full Text] [Related]

  • 42. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
    Snyder RD, Malick NC.
    Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
    [Abstract] [Full Text] [Related]

  • 43. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L, Plunkett W, Liliemark J, Gandhi V, Iacoboni S, Keating M.
    Leukemia; 1987 Sep; 1(9):638-43. PubMed ID: 3478543
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Bhalla K, McCrady C.
    Leuk Res; 1991 Sep; 15(4):205-13. PubMed ID: 2030601
    [Abstract] [Full Text] [Related]

  • 46. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M, Takimoto T, Tanizawa A, Akiyama Y, Mikawa H.
    Biochem Pharmacol; 1988 May 01; 37(9):1745-9. PubMed ID: 2454114
    [Abstract] [Full Text] [Related]

  • 47. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Zittoun J, Marquet J, David JC, Maniey D, Zittoun R.
    Cancer Chemother Pharmacol; 1989 May 01; 24(4):251-5. PubMed ID: 2752506
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics of the 5'-triphosphates of arabinosylcytosine and 2',2'-difluorodeoxycytidine in L1210 cells.
    Plunkett W, Grindey GB.
    Nucleic Acids Symp Ser; 1987 May 01; (18):77-9. PubMed ID: 3697155
    [Abstract] [Full Text] [Related]

  • 49. Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C.
    Plunkett W, Liliemark JO, Estey E, Keating MJ.
    Semin Oncol; 1987 Jun 01; 14(2 Suppl 1):159-66. PubMed ID: 3589690
    [No Abstract] [Full Text] [Related]

  • 50. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 51. Deoxycytidine kinase, thymidine kinase and cytidine deaminase and the formation of Ara-CTP in leukemic cells in different phases of the cell cycle.
    Richel DJ, Colly LP, Arentsen-Honders MW, Starrenburg CW, Willemze R.
    Leuk Res; 1990 Apr 01; 14(4):363-9. PubMed ID: 2159090
    [Abstract] [Full Text] [Related]

  • 52. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Apr 01; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 53. In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells.
    Muus P, Drenthe-Schonk A, Haanen C, Wessels H, Linssen P.
    Leuk Res; 1987 Apr 01; 11(4):319-25. PubMed ID: 3470578
    [Abstract] [Full Text] [Related]

  • 54. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Cancer Chemother Pharmacol; 1992 Apr 01; 31(1):11-7. PubMed ID: 1458554
    [Abstract] [Full Text] [Related]

  • 55. Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
    Harris AL, Grahame-Smith DG.
    Cancer Chemother Pharmacol; 1981 Apr 01; 5(3):185-92. PubMed ID: 6945922
    [Abstract] [Full Text] [Related]

  • 56. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
    Gandhi V, Plunkett W.
    Biochem Pharmacol; 1989 Oct 15; 38(20):3551-8. PubMed ID: 2479383
    [Abstract] [Full Text] [Related]

  • 57. Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity.
    Köhl U, Schwabe D, Montag E, Bauer S, Mieth B, Cinatl J, Cinatl J, Rohrbach E, Mainke M, Weissflog A.
    Eur J Cancer; 1995 Oct 15; 31A(2):209-14. PubMed ID: 7718327
    [Abstract] [Full Text] [Related]

  • 58. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC, Hutchinson DJ, Schmid FA, Philips FS.
    Cancer Res; 1975 Jan 15; 35(1):225-36. PubMed ID: 1109791
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemia.
    Liliemark JO, Gahrton G, Paul CY, Peterson CO.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):167-71. PubMed ID: 3589691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.